Abbott Laboratories Comprehensive Income 2010-2024 | ABT

Abbott Laboratories comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Abbott Laboratories comprehensive income for the quarter ending September 30, 2024 was $-8.135B, a 0.79% increase year-over-year.
  • Abbott Laboratories comprehensive income for 2023 was $-7.839B, a 2.63% decline from 2022.
  • Abbott Laboratories comprehensive income for 2022 was $-8.051B, a 3.86% decline from 2021.
  • Abbott Laboratories comprehensive income for 2021 was $-8.374B, a 6.39% decline from 2020.
Abbott Laboratories Annual Comprehensive Income
(Millions of US $)
2023 $-7,839
2022 $-8,051
2021 $-8,374
2020 $-8,946
2019 $-8,465
2018 $-7,586
2017 $-6,062
2016 $-7,263
2015 $-6,658
2014 $-5,053
2013 $-2,012
2012 $-3,594
2011 $-2,597
2010 $-1,367
2009 $854
Abbott Laboratories Quarterly Comprehensive Income
(Millions of US $)
2024-06-30 $-8,135
2024-03-31 $-8,166
2023-12-31 $-7,839
2023-09-30 $-8,480
2023-06-30 $-8,071
2023-03-31 $-8,039
2022-12-31 $-8,051
2022-09-30 $-9,445
2022-06-30 $-8,706
2022-03-31 $-8,474
2021-12-31 $-8,374
2021-09-30 $-9,240
2021-06-30 $-9,066
2021-03-31 $-9,285
2020-12-31 $-8,946
2020-09-30 $-9,044
2020-06-30 $-9,080
2020-03-31 $-9,386
2019-12-31 $-8,465
2019-09-30 $-7,763
2019-06-30 $-7,365
2019-03-31 $-7,470
2018-12-31 $-7,586
2018-09-30 $-7,009
2018-06-30 $-6,913
2018-03-31 $-5,733
2017-12-31 $-6,062
2017-09-30 $-6,116
2017-06-30 $-6,250
2017-03-31 $-6,532
2016-12-31 $-7,263
2016-09-30 $-6,533
2016-06-30 $-7,223
2016-03-31 $-6,851
2015-12-31 $-6,658
2015-09-30 $-7,211
2015-06-30 $-5,004
2015-03-31 $-5,607
2014-12-31 $-5,053
2014-09-30 $-2,975
2014-06-30 $-1,952
2014-03-31 $-1,934
2013-12-31 $-2,012
2013-09-30 $-2,957
2013-06-30 $-3,226
2013-03-31 $-2,895
2012-12-31 $-3,594
2012-09-30 $-2,756
2012-06-30 $-3,544
2012-03-31 $-1,941
2011-12-31 $-2,597
2011-09-30 $-860
2011-06-30 $578
2011-03-31 $182
2010-12-31 $-1,367
2010-09-30 $-1,483
2010-06-30 $-2,629
2010-03-31 $-976
2009-12-31 $854
2009-09-30 $499
2009-06-30 $-7
2009-03-31 $-1,195
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $202.220B $40.109B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Stryker (SYK) United States $143.322B 32.30
Boston Scientific (BSX) United States $130.065B 37.39
Medtronic (MDT) Ireland $112.498B 16.74
EssilorLuxottica (ESLOY) France $111.686B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.423B 0.00
Haleon (HLN) United Kingdom $43.501B 28.26
GE HealthCare Technologies (GEHC) United States $39.264B 20.36
ResMed (RMD) United States $37.048B 30.44
Terumo (TRUMY) Japan $29.575B 41.77
Koninklijke Philips (PHG) Netherlands $25.012B 19.14
Zimmer Biomet Holdings (ZBH) United States $21.536B 13.71
Insulet (PODD) United States $18.791B 74.86
Baxter (BAX) United States $17.673B 11.51
Smith & Nephew SNATS (SNN) United Kingdom $10.619B 0.00
Bio-Rad Laboratories (BIO) United States $10.338B 35.13
BellRing Brands (BRBR) United States $9.136B 38.63
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $6.084B 14.14
Haemonetics (HAE) United States $4.474B 21.43
TG Therapeutics (TGTX) United States $4.460B 0.00
ICU Medical (ICUI) United States $4.318B 41.21
Prestige Consumer Healthcare (PBH) United States $3.983B 19.75
Perrigo (PRGO) Ireland $3.596B 10.59
Neogen (NEOG) United States $3.517B 40.57
Envista Holdings (NVST) United States $3.509B 26.14
Agios Pharmaceuticals (AGIO) United States $3.368B 0.00
GN Store Nord (GNNDY) Denmark $3.041B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.942B 18.94
LeMaitre Vascular (LMAT) United States $2.342B 56.97
Warby Parker (WRBY) United States $1.964B 0.00
Green Thumb Industries (GTBIF) United States $1.888B 33.04
AtriCure (ATRC) United States $1.826B 0.00
InMode (INMD) Israel $1.630B 9.80
Curaleaf Holdings (CURLF) Canada $1.384B 0.00
AdaptHealth (AHCO) United States $1.357B 9.70
Maravai LifeSciences Holdings (MRVI) United States $1.280B 0.00
BioLife Solutions (BLFS) United States $1.206B 0.00
Owens & Minor (OMI) United States $0.995B 7.77
Phibro Animal Health (PAHC) United States $0.966B 17.04
CeriBell (CBLL) United States $0.962B 0.00
National Vision Holdings (EYE) United States $0.906B 30.29
Capricor Therapeutics (CAPR) United States $0.895B 0.00
Evolus (EOLS) United States $0.866B 0.00
Verano Holdings (VRNOF) United States $0.691B 0.00
Cresco Labs (CRLBF) United States $0.605B 0.00
VAREX IMAGING (VREX) United States $0.582B 17.56
Quanterix (QTRX) United States $0.580B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Valneva SE (VALN) France $0.426B 0.00
Canopy Growth (CGC) Canada $0.398B 0.00
ZimVie (ZIMV) United States $0.393B 33.12
Viemed Healthcare (VMD) United States $0.353B 33.59
Cerus (CERS) United States $0.331B 0.00
OraSure Technologies (OSUR) United States $0.320B 21.45
Sanara MedTech (SMTI) United States $0.308B 0.00
Biote (BTMD) United States $0.301B 13.90
Zynex (ZYXI) United States $0.287B 60.07
Jin Medical (ZJYL) China $0.284B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
TerrAscend (TSNDF) Canada $0.269B 0.00
Aurora Cannabis (ACB) Canada $0.264B 0.00
Omeros (OMER) United States $0.256B 0.00
Utah Medical Products (UTMD) United States $0.236B 15.90
High Tide (HITI) Canada $0.221B 91.67
Brainsway (BWAY) Israel $0.181B 217.20
Organigram Holdings (OGI) Canada $0.172B 0.00
FitLife Brands (FTLF) United States $0.151B 20.39
Rockwell Medical (RMTI) United States $0.137B 0.00
TriSalus Life Sciences (TLSI) United States $0.129B 0.00
Quipt Home Medical (QIPT) United States $0.116B 0.00
Zevia PBC (ZVIA) United States $0.111B 0.00
Veru (VERU) United States $0.107B 0.00
Ayr Wellness (AYRWF) United States $0.104B 0.00
Fonar (FONR) United States $0.095B 9.82
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.10
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.67
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
MariMed (MRMD) United States $0.062B 0.00
Safety Shot (SHOT) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Exagen (XGN) United States $0.050B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
Nephros (NEPH) United States $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.20
SNDL (SNDL) Canada $0.000B 0.00